# Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients With Prostate Volumes ≤ 40 ml: A Prospective Comparative Study

> **NCT06809205** · PHASE4 · COMPLETED · sponsor: **Fayoum University Hospital** · enrollment: 95 (actual)

## Conditions studied

- BPH With Other Lower Urinary Tract Symptoms

## Interventions

- **DRUG:** Tamsulosin 0.4 mg
- **DRUG:** Tadalafil 5mg
- **DRUG:** Tamsulosin and Tadalafil

## Key facts

- **NCT ID:** NCT06809205
- **Lead sponsor:** Fayoum University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-20
- **Primary completion:** 2024-05-20
- **Final completion:** 2024-08-30
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06809205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06809205, "Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients With Prostate Volumes ≤ 40 ml: A Prospective Comparative Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06809205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*